Menu Bar

Home           Calendar           Topics          Just Charlestown          About Us

Thursday, February 22, 2024

How COVID-19 Affects the Brain

Headaches, Memory Problems, and Fatigue 

By CHARITÉ - UNIVERSITÄTSMEDIZIN BERLIN 

Headaches, memory problems, and fatigue are just some of the neurological impacts that arise during coronavirus infection and can last well beyond the acute period. 

Even early on in the pandemic, researchers surmised that direct infection of the brain could be the cause.

“We took that as our hypothesis at the start, too. But so far, there has been no clear evidence that the coronavirus can persist in the brain, let alone proliferate,” explains Dr. Helena Radbruch, head of the Chronic Neuroinflammation working group at the Department of Neuropathology at Charité. 

“For that, we would have needed to find evidence of intact virus particles in the brain, for example. Instead, the indications that the coronavirus could infect the brain come from indirect testing methods, so they aren’t entirely conclusive.”

According to a second hypothesis, the neurological symptoms would instead be a kind of side effect of the strong immune response the body deploys to defend against the virus. 

Past studies have produced indications that this might be the case. The current Charité study now bolsters this theory with detailed molecular biology and anatomical results from autopsies.

No Signs of Direct Infection of the Brain

For the study, the team of researchers analyzed various areas of the brain in 21 people who died in hospital settings, typically in an ICU, due to severe coronavirus infection. For comparison, the researchers studied nine patients who died of other causes after treatment in intensive care. 

First, they looked to see whether the tissue showed any visible changes and hunted for any indication of coronavirus. Then they conducted a detailed analysis of genes and proteins to identify the specific processes that had taken place inside individual cells.

Like other teams of researchers before them, the Charité scientists found coronavirus genetic material in the brain in some cases. “But we didn’t find neurons infected with SARS-CoV-2,” Radbruch notes. 

“We assume that immune cells absorbed the virus in the body and then traveled to the brain. They’re still carrying the virus, but it doesn’t infect cells of the brain. So coronavirus has invaded other cells in the body, but not the brain itself.”

Brain Reacts to Inflammation in the Body

Still, the researchers did note striking changes in molecular processes in some cells of the brain in those infected with COVID-19: For example, the cells ramped up the interferon signaling pathway, which is typically activated in the course of a viral infection.

“Some neurons evidently react to the inflammation in the rest of the body,” says Prof. Christian Conrad, head of the Intelligent Imaging working group at the Berlin Institute of Health at Charité (BIH) and one of the principal investigators in the study, along with Radbruch. 

“This molecular reaction could be a good explanation for the neurological symptoms we see in COVID-19 patients. For example, neurotransmitters emitted by these cells in the brainstem could cause fatigue. That’s because the brainstem is home to groups of cells that control drive, motivation, and mood.”

The reactive nerve cells were found primarily in what are known as the nuclei of the vagus nerve. These are nerve cells located in the brainstem that extend all the way to organs such as the lungs, intestine, and heart. 

“In simplified terms, our interpretation of our data is that the vagus nerve ‘senses’ the inflammatory response in different organs of the body and reacts to it in the brainstem – without there being any actual infection of brain tissue,” Radbruch explains. “Through this mechanism, the inflammation does spread from the body to the brain in a way, which can disrupt brain function.”

Limited-Time Reaction

The neurons’ reaction to the inflammation is temporary, as shown by a comparison of people who died during an acute coronavirus infection with those who died at least two weeks afterward. The molecular changes are most evident during the acute infection phase, but they do normalize again afterward – at least in the vast majority of cases.

“We think it’s possible that if the inflammation becomes chronic, that could be what causes the neurological symptoms often observed in long COVID in some people,” Conrad says. To follow up on this suspicion, the team of researchers is now planning to study the molecular signatures in the cerebral fluid of long COVID patients in greater detail.

Reference: “Proteomic and transcriptomic profiling of brainstem, cerebellum and olfactory tissues in early- and late-phase COVID-19” by Josefine Radke, Jenny Meinhardt, Tom Aschman, Robert Lorenz Chua, Vadim Farztdinov, Sören Lukassen, Foo Wei Ten, Ekaterina Friebel, Naveed Ishaque, Jonas Franz, Valerie Helena Huhle, Ronja Mothes, Kristin Peters, Carolina Thomas, Shirin Schneeberger, Elisa Schumann, Leona Kawelke, Julia Jünger, Viktor Horst, Simon Streit, Regina von Manitius, Péter Körtvélyessy, Stefan Vielhaber, Dirk Reinhold, Anja E. Hauser, Anja Osterloh, Philipp Enghard, Jana Ihlow, Sefer Elezkurtaj, David Horst, Florian Kurth, Marcel A. Müller, Nils C. Gassen, Julia Melchert, Katharina Jechow, Bernd Timmermann, Camila Fernandez-Zapata, Chotima Böttcher, Werner Stenzel, Elke Krüger, Markus Landthaler, Emanuel Wyler, Victor Corman, Christine Stadelmann, Markus Ralser, Roland Eils, Frank L. Heppner, Michael Mülleder, Christian Conrad and Helena Radbruch, 16 February 2024, Nature Neuroscience.
DOI: 10.1038/s41593-024-01573-y